EUVIMEDEUVIMED entdecken
Crossref

Prodigiosin Loaded SN‐PB@PG NPs‐Based Multimodal Therapy for the Healing of Bacterial Infected Chronic Wounds

Zhou Wu, Li Chang, Changling Li, Pengxiang Xu, Liuying Liu, Aidi Tong, Yilong Li, Chunyi Tong iD, Bin Liu

Advanced Healthcare Materials · 2025

DOI: 10.1002/adhm.202405100 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2025. Verfasst von Zhou Wu und 8 weiteren Autor:innen. Beteiligte Einrichtung: College of Biology, Hunan University, Changsha, 410082, China. Hauptthemen laut MEDLINE: Prodigiosin, Wound Healing, Nanoparticles, Wound Infection. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 54 Literaturangaben. Gefördert von: Natural Science Foundation of Hunan Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Healing of infected chronic wounds faces dual challenges: persistent inflammation and impaired angiogenesis. To address these, SN‐PB@PG nanocomplexes were prepared by hybridisation of nitroprusside (SNP) with Prussian blue (SN‐PB NPs) and loaded with prodigiosin (PG). Under near‐infrared (NIR) irradiation, SN‐PB NPs generated mild hyperthermia, facilitating the release of nitric oxide (NO) and PG to combat bacterial biofilms and multidrug‐resistant pathogens. The in vivo assay using diabetic infected wounds demonstrated that SN‐PB@PG NPs with NIR reduced the wound area to 10.6% by the 11th day, which is superior to that of control group (29.6%). In the flap transplantation experiments, the data showed SN‐PB@PG NPs with NIR group only have a necrobiosis of 3.8% of flaps on the 8th day, which is superior to 31.3% of the control group. Additionally, the release of NO promoted vascular regeneration by up‐regulating vascular endothelial growth factor (VEGF) and platelet endothelial cell adhesion molecule‐1 (CD31), and regenerated sarcomeric tissue by down‐regulating MMP‐9. The results indicated that the combination of SN‐PB@PG NPs with gas and photothermal therapy exerted a combined antibacterial and wound healing effect. Compared to traditional clinical methods such as surgical debridement and hyperbaric oxygen therapy, this new strategy efficiently addresses issues of infection and healing, which is convenient for clinical application.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ProdigiosinWound HealingNanoparticlesWound InfectionBacterial InfectionsAnimalsMiceMaleNitric OxideCombined Modality TherapyAnti-Bacterial AgentsHumansBiofilms

Stichwörter der Autor:innen

antimicrobialinfected woundnitric oxideprodigiosinskin flap model

Substanzen

ProdigiosinNitric OxideAnti-Bacterial Agents

Autor:innen und Institutionen

  • College of Biology, Hunan University, Changsha, 410082, China.
  • Institute of Bast Fiber Crop Chinese Academy of Agriculture Sciences, Changsha, 410205, China.
  • College of Biological and Food Engineering, Huaihua University, Huaihua, 418000, China.
  • Zonsen PepLib Biotech Inc., Shifeng District, Zhuzhou, 412000, China.

ORCID-Profile: Chunyi Tong

Förderung

  • Natural Science Foundation of Hunan Province

Zitieren

APA

Wu, Z., Chang, L., Li, C., Xu, P., Liu, L., Tong, A., Li, Y., Tong, C., & Liu, B. (2025). Prodigiosin Loaded SN‐PB@PG NPs‐Based Multimodal Therapy for the Healing of Bacterial Infected Chronic Wounds. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202405100

Vancouver

Wu Z, Chang L, Li C, Xu P, Liu L, Tong A, et al. Prodigiosin Loaded SN‐PB@PG NPs‐Based Multimodal Therapy for the Healing of Bacterial Infected Chronic Wounds. Advanced Healthcare Materials. 2025. doi:10.1002/adhm.202405100

BibTeX
@article{Wu2025,
  author = {Wu, Zhou and Chang, Li and Li, Changling and Xu, Pengxiang and Liu, Liuying and Tong, Aidi and Li, Yilong and Tong, Chunyi and Liu, Bin},
  title = {Prodigiosin Loaded SN‐PB@PG NPs‐Based Multimodal Therapy for the Healing of Bacterial Infected Chronic Wounds},
  journal = {Advanced Healthcare Materials},
  year = {2025},
  doi = {10.1002/adhm.202405100}
}
Kostenlos starten →